Navigation Links
Elsevier introduces innovative new pharmacology text
Date:12/7/2009

Philadelphia, PA, 7 December 2009 Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the early success and rapid acceptance of its recently released Pharmacology and Therapeutics: Principles to Practice (http://www.us.elsevierhealth.com/isbn/9781416032915/Pharmacology-and-Therapeutics), an innovative new pharmacology textbook designed to better meet the needs of today's residents and practitioners. In just a few short months since its introduction, the book has garnered critical acclaim and has earned its place among other more established pharmacology reference books (http://www.us.elsevierhealth.com/medicine/pharmacology).

Up until now, pharmacology references have focused on either the basic or clinical aspects of the field. By contrast, Pharmacology and Therapeutics encompasses the entire continuum from underlying science through innovation, translation, regulation, and clinical implementation, providing the integrated perspectives that are needed to fully master human therapeutics today.

Edited by Drs. Scott Waldman and Andre Terzic both past presidents of the American Society for Clinical Pharmacology and Therapeutics the book features contributions from many of the most respected names in pharmacology. These authors, all leaders in their respective disciplines, establish the standards for translating fundamental observations in the laboratory into novel therapeutic approaches for managing patients including rapidly growing areas such as pharmacogenetics and pharmacogenomics, regenerative pharmacology, stem cell therapies, and the emerging field of individualized medicine. Evidence-based therapeutic guidelines are included throughout, where available, as are appropriate discussions of nutrition, complementary and alternative medicines, nutraceuticals, and dietary supplements.

"I applaud the Editors for bringing together, between the covers of this first edition, a superb textbook bridging basic and clinical pharmacology, from classic principles to future concepts," writes Nobel Laureate Ferid Murad, MD, PhD in the book's Foreword. "This exciting textbook will be invaluable to students, scholars, and professionals across the practice in human therapeutics."

"This is an outstanding textbook that connects the recent advances in basic principles with the practice of medicine," added Thomas L. Pazdernik, PhD, University of Kansas Medical Center. "It is a must-have book for those involved in drug discovery, translational research, and the teaching of evidence-based medicine."

In its June 2009 issue, the British Journal of Hospital Medicine cites the narrative as " so easy to read that it makes extracting the information from the pages almost effortless. Every chapter is supported by a good selection of references to original research and review articles, both old and new, and the whole text is available online allowing it to be accessed wherever there is internet connection."


'/>"/>

Contact: Tom Reller
t.reller@elsevier.com
212-462-1912
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier launches new journal: Stem Cell Research
2. Elsevier announces new journal on inflammatory bowel diseases
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
5. Elsevier journals participate widely in global theme issue on poverty and human development
6. ScienceDirect to host French-language journals from Elsevier Masson
7. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
8. Elseviers WiserWiki allows physicians to update evidence-based medical information
9. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
10. Elsevier Foundation announces grants for innovative libraries and new scholars
11. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... 20, 2017 , ... Announced that Clear Global ... services market) has entered into an agreement on September 1, 2017 with The ... is the first private Dental School to launch an online, accredited Post Graduate ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... gather for the National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New ... It is also when Athletic Trainers are acknowledged by their peers with accolades ...
(Date:9/20/2017)... ... 2017 , ... Five consumer packaged goods (CPG) products were selected by the ... Nopavera Plus was named to the short list in the Specialty Supplements ... during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort ...
(Date:9/20/2017)... Eugene, OR (PRWEB) , ... September 20, 2017 , ... ... OSHA 10- and 30-Hour and HAZWOPER 8-, 24- and 40-Hour courses from now until ... , In addition to offering these discounted prices to all businesses and government ...
(Date:9/20/2017)... ... ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A Bible-inspired ... the creation of published author, Bill Miller. Bill Miller has a unique ... than a decade of addiction to prescription drugs. He has a Bachelor ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
Breaking Medicine Technology: